An in vitro comparison of intra-operative isohemagglutinin and human leukocyte antigen removal techniques in pediatric heart transplantation

Authors: Hayes Emily A., Walczak Ashley B, Goodhue Meyer Erin, Nicol Kathleen, Deitemyer Matthew, Duffy Vicky, Moore Padilla Michelle, Gajarski Robert J., Nandi Deipanjan

Source: The Journal of ExtraCorporeal Technology, Vol 55, Iss 4, Pp 189-193 (2023)

Subject Terms: isohemagglutinin, human leukocyte antigen, plasmapheresis, pediatric heart transplantation, Medicine

File Description: electronic resource

Relation: https://ject.edpsciences.org/articles/ject/full_html/2023/04/ject230007/ject230007.html; https://doaj.org/toc/0022-1058; https://doaj.org/toc/2969-8960

Access URL: https://doaj.org/article/915ba50999cb456191773bb1fc5faa25

Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial

Authors: Thiruvengadam, Swetha Kambhampati, Fakhri, Bita, Ai, Weiyun Z., Kaplan, Lawrence D., Tuscano, Joseph M., Wieduwilt, Matthew J., Sudhindra, Akshay, Cavallone, Erika, Reiner, Jesika, Aoun, Charlie, Castillo, Miguel, Martinelli, Michelle, Ta, Teresa, Le, Diem, Padilla, Michelle, Crawford, Erika, Andreadis, Charalambos B.

Source: In Clinical Lymphoma, Myeloma and Leukemia March 2021 21(3):139-146

An investigation of stigma in individuals receiving treatment for substance abuse

Authors: Luoma, Jason B., Twohig, Michael P., Waltz, Thomas, Hayes, Steven C., Roget, Nancy, Padilla, Michelle, Fisher, Gary

Source: In Addictive Behaviors 2007 32(7):1331-1346

A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and Tacrolimus

Authors: Koura, Divya, Mirocha, James, Dykes, Kaitlyn C, Hamdan, Ayad, Goodman, Aaron, Tanaka, Tiffany N, Mulroney, Carolyn M., Costello, Caitlin L., Mangan, James K., Ball, Edward D., Jeong, Ah-Reum, Maroge, Joseph, Padilla, Michelle, Tzachanis, Dimitrios

Source: In Blood 2 November 2023 142 Supplement 1:3551-3551

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Early Relapsed/Refractory Multiple Myeloma

Authors: Kumar, Anupama, Rosenberg, Aaron S, Padilla, Michelle ^*, Shah, Nina, Sirianni, Lindsey ^*, Liu, Lin ^*, Cheng, Yuwei ^*, Pittman, Emily ^*, Tzachanis, Dimitrios, Larson, Sarah, Mulroney, Carolyn, Ball, Edward D. ^*, Costello, Caitlin

Source: In Blood 15 November 2022 140 Supplement 1:4436-4437

P-252: Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma

Authors: Kumar, Anupama, Rosenberg, Aaron, Padilla, Michelle, Liu, Lin, Cheng, Yuwei, Pittman, Emily, Tzachanis, Dimitrios, Larson, Sarah, Shah, Nina, Mulroney, Carolyn, Ball, Edward, Costello, Caitlin

Source: In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S174-S175

A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-Free Graft-Versus-Host Disease Prophylaxis Regimen with Post-Transplantation Cyclophosphamide and Abatacept to Standard of Care

Authors: Koura, Divya, Tzachanis, Dimitrios, Ball, Edward D., Costello, Caitlin, Goodman, Aaron M, Mangan, James K., Mulroney, Carolyn, Maroge, Joseph, Padilla, Michelle, Breslin, Peggy, Garrett, Jodi, McConnell, Kimberly

Source: In Blood 23 November 2021 138 Supplement 1:1816-1816

Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.

Authors: Kambhampati, Swetha, Fakhri, Bita, Ai, Weiyun Z., Kaplan, Lawrence D., Tuscano, Joseph M., Wieduwilt, Matthew J., Sudhindra, Akshay, Cavallone, Erika, Reiner, Jesika, Aoun, Charlie, Castillo, Miguel, Martinelli, Michelle, Ta, Teresa, Le, Diem, Padilla, Michelle, Crawford, Erika, Andreadis, Charalambos B.

Source: Clinical Lymphoma, Myeloma & Leukemia; Mar2021, Vol. 21 Issue 3, p139-146, 8p

Right Ventricular Arterial Elastance is Associated with Prognostic Value in one Year Mortality Following Left Ventricular Assist Device Placement

Authors: Moore Padilla, Michelle M., Derbala, Mohamed, Kumar, Salil, Ferrall, Joel, Guo, Aaron, Cefalau, Matthew, Sims, Daniel, Smith, Sakima

Source: In Journal of Cardiac Failure October 2020 26(10) Supplement:S139-S140

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Safety Run-in Analysis

Authors: Costello, Caitlin L., Padilla, Michelle ^*, Ball, Edward D. ^*, Mulroney, Carolyn

Source: In Blood 13 November 2019 134 Supplement 1:3117-3117

A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Authors: Kambhampati, Swetha, Fakhri, Bita, Ai, Weiyun, Kaplan, Lawrence D, Tuscano, Joseph, Wieduwilt, Matthew J., Sudhindra, Akshay, Hwang, Jimmy ^*, Reiner, Jesika ^*, Martinelli, Michelle ^*, Aoun, Charlie ^*, Ta, Teresa ^*, Le, Diem ^*, Padilla, Michelle ^*, Crawford, Erika ^*, Andreadis, Charalambos

Source: In Blood 13 November 2019 134 Supplement 1:2828-2828

Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma

Authors: Costello, Caitlin, Ball, Edward, Mulroney, Carolyn, Padilla, Michelle

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e360-e360

Augmenting continuing education with psychologically focused group consultation: Effects on adoption of group drug counseling.

Authors: Luoma, Jason B., ORCID 0000-0002-3601-7037. Department of Psychology, University of Nevada, Reno, NV, US, jbluoma@gmail.com, Hayes, Steven C., ORCID 0000-0003-4399-6859. Department of Psychology, University of Nevada, Reno, NV, US, Twohig, Michael P.. Department of Psychology, University of Nevada, Reno, NV, US, Roget, Nancy. Center for Addictions and Substance Abuse Technologies, University of Nevada, Reno, NV, US, Fisher, Gary. Center for Addictions and Substance Abuse Technologies, University of Nevada, Reno, NV, US, Padilla, Michelle. Center for Addictions and Substance Abuse Technologies, University of Nevada, Reno, NV, US, Bissett, Richard. Center for Addictions and Substance Abuse Technologies, University of Nevada, Reno, NV, US, Holt, Charles. Private Practice, Reno, NV, US, Kohlenberg, Barbara. University of Nevada School of Medicine, Reno, NV, US

Source: Psychotherapy, Vol 44(4), Dec, 2007. pp. 463-469.

NLM Title Abbreviation: Psychotherapy (Chic)

Publisher: US : Educational Publishing Foundation

Other Journal Titles: Psychotherapy; Psychotherapy: Theory, Research & Practice

Other Publishers: US : Division of Psychotherapy (29), American Psychological Association

Publication Type: Journal; Peer Reviewed Journal

FONTAN-ASSOCIATED LIVER DISEASE: IS INSULIN SENSITIVITY IMPORTANT?

Authors: Dodeja, Anudeep (AUTHOR), Urbina, Francesca (AUTHOR), Moore-Padilla, Michelle (AUTHOR), Mah, May Ling (AUTHOR), Bradley, David (AUTHOR), Bradley, Elisa (AUTHOR)

Source: Journal of the American College of Cardiology (JACC). 2020 Supplement 1, Vol. 75, p549-549. 1p.

Subject Terms: *INSULIN resistance, *LIVER diseases, *CONGENITAL heart disease